Rupak Nagraik

Dr. Rupak Nagraik


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2020 in 3 Biotech
Verified
Journal Article
Closed access
PDF file
DKDeepak Kala
Deepak Kala
SGShagun Gupta
Shagun Gupta
RNRupak Nagraik
Rupak Nagraik
VVVivek Verma
Vivek Verma
ATAtul Thakur
Atul Thakur
AKAnkur Kaushal
Ankur Kaushal

18 May 2021 in International Journal of Environmental Science and Technology
Verified
Journal Article
Closed access
PDF file
ABA. Baruah
A. Baruah
ASA. Sharma
A. Sharma
SSS. Sharma
S. Sharma
RNRupak Nagraik
Rupak Nagraik

29 January 2023 in Biosensors
Verified
Journal Article
Open access
PDF file
AKAkash Kumaran
Akash Kumaran
NSNathan Jude Serpes
Nathan Jude Serpes
TGTisha Gupta
Tisha Gupta
AJAbija James
Abija James
ASAvinash Sharma
Avinash Sharma
SPSadanand Pandey
Sadanand Pandey
With the move of molecular tests from diagnostic labs to on-site testing becoming more common, there is a sudden rise in demand for nucleic acid-based diagnostic tools that are selective, sensitive, flexible to terrain changes, and cost-effective to assist in point-of-care systems for large-scale screening and to be used in remote locations in cases of outbreaks and pandemics. CRISPR-based biosensors comprise a promising new approach to nucleic acid detection, which uses Cas effector proteins (Cas9, Cas12, and Cas13) as extremely specialized identification components that may be used in conjunction with a variety of readout approaches (such as fluorescence, colorimetry, potentiometry, lateral flow assay, etc.) for onsite analysis. In this review, we cover some technical aspects of integrating the CRISPR Cas system with traditional biosensing readout methods and amplification technologies such as polymerase chain reaction (PCR), loop-mediated isothermal amplification (LAMP), and recombinase polymerase amplification (RPA) and continue to elaborate on the prospects of the developed biosensor in the detection of some major viral and bacterial diseases. Within the scope of this article, we also discuss the recent COVID pandemic and the numerous CRISPR biosensors that have undergone development since its advent. Finally, we discuss some challenges and future prospects of CRISPR Cas systems in point-of-care testing.

16 October 2020 in Animals
Verified
Journal Article
Open access
PDF file
HKHarsh Kumar
Harsh Kumar
Bing-Huei ChenBing-Huei Chen
Bing-Huei Chen
Kamil KucaKamil Kuca
Kamil Kuca
Eugenie  NepovimovaEugenie Nepovimova
Eugenie Nepovimova
AKAnkur Kaushal
Ankur Kaushal
DKDinesh Kumar
Dinesh Kumar
Progress in the medical profession is determined by the achievements and effectiveness of new antibiotics in the treatment of microbial infections. However, the development of multiple-drug resistance in numerous bacteria, especially Gram-negative bacteria, has limited the treatment options. Due to this resistance, the resurgence of cyclic polypeptide drugs like colistin remains the only option. The drug, colistin, is a well-known growth inhibitor of Gram-negative bacteria like Acinetobacter baumanni, Enterobacter cloacae, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Technological advancements have uncovered the role of the mcr-1(mobilized colistin resistance) gene, which is responsible for the development of resistance in Gram-negative bacteria, which make them distinct from other bacteria without this gene. Additionally, food animals have been determined to be the reservoir for colistin resistance microbes, from which they spread to other hosts. Due to the adverse effects of colistin, many developed countries have prohibited its usage in animal foods, but developing countries are still using colistin in animal food production, thereby imposing a major risk to the public health. Therefore, there is a need for implementation of sustainable measures in livestock farms to prevent microbial infection. This review highlights the negative effects (increased resistance) of colistin consumption and emphasizes the different approaches used for detecting colistin in animal-based foods as well as the challenges associated with its detection.

1 May 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
ATAkriti Taneja
Akriti Taneja
RSRuchi Sharma
Ruchi Sharma
SKShreya Khetrapal
Shreya Khetrapal
ASAvinash Sharma
Avinash Sharma
RNRupak Nagraik
Rupak Nagraik
Deepak KumarDeepak Kumar
Deepak Kumar
Overall, combating food waste necessitates a multifaceted approach that includes education, infrastructure, and policy change. By working together to implement these strategies, we can help reduce the negative impacts of food waste and create a more sustainable and equitable food system. The sustained supply of nutrient-rich agrifood commodities is seriously threatened by inefficiencies caused by agricultural losses, which must be addressed. As per the statistical data given by the Food and Agriculture Organisation (FAO) of the United Nations, nearly 33.33% of the food that is produced for utilization is wasted and frittered away on a global level, which can be estimated as a loss of 1.3 billion metric tons per annum, which includes 30% cereals, 20% dairy products 35% seafood and fish, 45% fruits and vegetables, and 20% of meat. This review summarizes the various types of waste originating from various segments of the food industry, such as fruits and vegetables, dairy, marine, and brewery, also focusing on their potential for developing commercially available value-added products such as bioplastics, bio-fertilizers, food additives, antioxidants, antibiotics, biochar, organic acids, and enzymes. The paramount highlights include food waste valorization, which is a sustainable yet profitable alternative to waste management, and harnessing Machine Learning and Artificial Intelligence technology to minimize food waste. Detail of sustainability and feasibility of food waste-derived metabolic chemical compounds, along with the market outlook and recycling of food wastes, have been elucidated in this review.

27 June 2022 in Journal of Medical Virology
Verified
Journal Article
Closed access
AKAkash K
Akash K
ASAvinash Sharma
Avinash Sharma
Deepak KumarDeepak Kumar
Deepak Kumar
SSSachin K. Singh
Sachin K. Singh
GGGaurav Gupta
Gaurav Gupta
RNRupak Nagraik
Rupak Nagraik